4//SEC Filing
Aker Christopher Ray 4
Accession 0000950170-24-062917
CIK 0001505512other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:20 PM ET
Size
5.3 KB
Accession
0000950170-24-062917
Insider Transaction Report
Form 4
Aker Christopher Ray
Sr. VP & General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2024-05-20+363,000→ 363,000 totalExercise: $2.01Exp: 2034-05-19→ Common Stock (363,000 underlying)
Footnotes (1)
- [F1]The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001762611
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:20 PM ET
- Size
- 5.3 KB